Sarah Hohl, MPH, PhD, is the Associate Scientist at the Cancer Center Cessation Initiative (C3I) Coordinating Center. Sarah leads the C3I efforts to evaluate reach, effectiveness, and sustainability of evidence-based tobacco cessation interventions across C3I sites.
Sarah is a mixed-methods researcher with expertise in evaluating multilevel, multisite collaboration and interventions that aim to improve health and health-services delivery, particularly among racial/ethnic minority, immigrant, and low-income populations. Her goal is to lead research and practice teams to reduce disparities in tobacco use, cancer, and chronic disease. Sarah has evaluated team collaboration and outcomes in national, multisite initiatives, including the NIH-funded Transdisciplinary Research on Energetics and Cancer (TREC) and the Centers for Population Health and Health Disparities (CPHHD). In her postdoctoral research, she evaluated adoption, feasibility, and sustainability of evidence-based interventions for cancer screening and screening disparities in the national CDC-funded Colorectal Cancer Control Program.
Prior to entering the field of U.S.-based tobacco use and disease prevention research, Sarah spent 10 years living and working in Africa and Asia, where she partnered with local agencies to implement programs that addressed health and its social determinants.
Sarah completed a postdoctoral fellowship in Implementation Science and Cancer Prevention at the University of Washington Health Promotion Research Center. She holds a PhD in Health Services with an emphasis in Social Determinants of Health and Health Behavior and an MPH in Global Health Policy and Management from the University of Washington. She earned a BA in Spanish from Xavier University in Cincinnati, Ohio and an honorary PhD in Procrastibaking from YouTube. She bakes custom sweets (gorgeous flavors, bold visual aesthetics, no soggy bottoms) under her alias, Dr. Cake.